This past summer, the pharmaceutical giant launched InnoCentive.com, a Web site where scientists from Big Pharma and start-up biotechs post problems for outside researchers to solve. Companies signed on to InnoCentive have posted organic chemistry problems carrying potential awards worth a total of $1.9 million, and the Web venture plans to unveil problems in molecular biology and genetics within the coming year. The private labs that post the problems benefit by expanding their scientific knowledge without paying salaries and benefits; the outside researchers who solve the puzzles benefit by collecting cash awards. "It was really fun," Sintim relates. "As students, we always do that—we have problems in class to solve. Initially, it was just a challenge: 'Let me see if I can do that.'"
Sintim's effort and award also provoked debate among university officials who were proud of his accomplishment but worried about some of its implications. Sintim got authorization ...